Edition:
United Kingdom

Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

11.01USD
23 May 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$11.01
Open
$10.96
Day's High
$11.07
Day's Low
$10.82
Volume
173,817
Avg. Vol
296,595
52-wk High
$20.85
52-wk Low
$9.51

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -1.632
FY 2018 Dec '18 0.00 -1.192
Sep '18 0.00 -0.912
Jun '18 0.00 -1.040
Mar '18 0.00 -1.733
FY 2017 Dec '17 0.94 -0.801
Sep '17 0.00 -0.923
Jun '17 0.68 -1.480
Mar '17 0.00 -1.991
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 11 0.00 0.00 0.00 4.40
Quarter Ending Sep-19 11 0.00 0.00 0.00 5.43
Year Ending Dec-19 13 0.00 0.00 0.00 25.59
Year Ending Dec-20 15 70.36 195.00 0.04 88.35
Earnings (per share)
Quarter Ending Jun-19 13 -0.98 -0.79 -1.37 -0.86
Quarter Ending Sep-19 13 -0.99 -0.88 -1.38 -1.12
Year Ending Dec-19 15 -4.46 -3.55 -5.76 -3.49
Year Ending Dec-20 15 -3.24 -1.45 -5.23 -2.64
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.23 35.62
P/E High - Last 5 Yrs. 96.10 165.32 57.66
P/E Low - Last 5 Yrs. 96.10 52.05 28.17
Beta 2.81 1.20 0.96
Price to Sales (TTM) -- 40.66 9.39
Price to Book (MRQ) 5.89 11.74 4.15
Price to Tangible Book (MRQ) 3.56 17.07 4.93
Price to Cash Flow (TTM) -- 62.55 24.39
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.66
Dividend Yield - 5 Year Avg -- 0.05 0.72
Dividend 5 Year Growth Rate -- 0.92 3.10
Payout Ratio(TTM) -- 1.37 15.30

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 58.80 16.58
Sales (TTM) vs TTM 1 Yr. Ago -100.00 43.52 8.18
Sales - 5 Yr. Growth Rate -- 33.04 10.42
EPS (MRQ) vs Qtr. 1 Yr. Ago 5.81 -8.95 19.52
EPS (TTM) vs TTM 1 Yr. Ago 3.26 -- --
EPS - 5 Yr. Growth Rate -- 22.24 7.23
Capital Spending - 5 Yr. Growth Rate 74.65 24.88 8.30

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.78 2.43
Current Ratio (MRQ) 8.34 3.83 3.36
LT Debt to Equity (MRQ) 70.99 7.63 14.46
Total Debt to Equity (MRQ) 70.99 20.75 19.91
Interest Coverage (TTM) -- 32.81 14.54

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 23.56 50.24
Gross Margin - 5 Yr. Avg. -- 59.36 51.30
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -1,426.75 -15.63 15.77
Operating Margin (TTM) -- -116.24 -5.00
Operating Margin - 5 Yr. Avg. -1,440.49 -31.45 11.00
Pre-Tax Margin (TTM) -- -116.31 -5.39
Pre-Tax Margin - 5 Yr. Avg. -1,449.62 -33.99 15.97
Net Profit Margin (TTM) -- -121.92 -9.16
Net Profit Margin - 5 Yr. Avg. -1,449.62 -38.94 11.18
Effective Tax Rate (TTM) -- 17.15 19.89
Effective Tax Rate - 5 Yr. Avg. -- 18.92 24.12

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 8,929,205 741,466,839
Net Income/Employee (TTM) -1,620,456 1,613,959 86,622,402
Receivable Turnover (TTM) -- 11.46 5.67
Inventory Turnover (TTM) -- 2.44 3.65
Asset Turnover (TTM) 0.00 0.33 0.79

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -58.84 6.17 9.41
Return on Assets - 5 Yr. Avg. -58.31 6.11 10.43
Return on Investment (TTM) -63.76 7.52 11.69
Return on Investment - 5 Yr. Avg. -62.41 7.99 13.28
Return on Equity (TTM) -145.22 8.09 16.40
Return on Equity - 5 Yr. Avg. -78.17 9.06 14.85
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % 1.55 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Alder Biopharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -18.71 -16.69 21 8
13 Week -20.80 -22.78 26 15
26 Week -15.50 -21.61 39 9
52 Week -26.11 -29.52 51 16
YTD 8.49 -4.78 51 8
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 187
Total Shares Held: 91,454,938
3 Mo. Net Change: 15,580,090
# New Positions: 24
# Closed Positions: 26
# Increased Positions: 89
# Reduced Positions: 67
# Net Buyers: 22
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.